Dupont De Nemours, INC 10-Q quarterly reports

DuPont de Nemours, Inc. announced Q2 2026 results with a 4% increase in net sales driven by organic growth in both its Healthcare & Water Technologies and Diversified Industrials segments.

DuPont de Nemours, Inc. reported Q1 2026 results with net sales up 4% to $1.7 billion, driven by organic growth and favorable currency impacts, and announced the completion of its Aramids business divestiture.

DuPont reports a net loss for Q3 2025 driven by significant charges related to the Electronics spin-off and Aramids divestiture, while continuing operations show sales growth.

DuPont reports mixed Q2 2025 results with net sales up 3% driven by ElectronicsCo volume, but net income significantly down due to a goodwill impairment charge and higher separation costs, as it targets a November 1, 2025 spin-off of its Electronics business.

DuPont's Q1 2025 results reveal a net loss driven by a significant goodwill impairment charge, alongside revenue growth and continued progress towards the separation of its Electronics business.

DuPont reported a 4% increase in net sales for Q3 2024 and is progressing with its plan to separate into three independent companies.

DuPont plans to separate into three independent publicly traded companies within 18 to 24 months, while reporting a 2% increase in net sales for the second quarter of 2024.

DuPont's first quarter 2024 results show a 3% decrease in net sales compared to the same period last year, influenced by volume declines and currency headwinds, partially offset by portfolio actions.